Showing results (71-80 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|August 9, 2020
Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after studyRefeletswe Lebelonyane, Pamela Bachanas, Lisa Block, et al.
The Lancet. HIV|August 9, 2020
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort studySergio Serrano-Villar, Javier Martínez-Sanz, Raquel Ron, et al.
The Lancet. HIV|August 11, 2020
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical modelsBritta L Jewell, Edinah Mudimu, John Stover, et al.
The Lancet. HIV|July 5, 2020
Cognitive disorders in people living with HIVAlan Winston, Serena Spudich
The Lancet. HIV|November 20, 2019
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trialJean-Michel Molina, Kathleen Squires, Paul E Sax, et al.
The Lancet. HIV|December 25, 2019
Trends in post-partum viral load among women living with perinatal HIV infection in the USA: a prospective cohort studyKunjal Patel, Brad Karalius, Kathleen Powis, et al.
The Lancet. HIV|December 12, 2018
Issues about periconception use of dolutegravir are reminiscent of early concerns about efavirenzVivian Black, Sheree R Schwartz
The Lancet. HIV|December 2, 2019
HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and useJohan Vekemans, William Snow, Patricia E Fast, et al.
The Lancet. HIV|February 17, 2020
The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling studyAdam Akullian, Michelle Morrison, Geoffrey P Garnett, et al.
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
Pageof 79